In 106 community-dwelling middle-aged non-smokers we examined the time-course and the acute effects of fine particles (PM 2.5 ) on heart rate variability (HRV), which measures cardiac autonomic modulation (CAM). Twenty-four hours beat-to-beat ECG data were visually examined. Artifacts and arrhythmic beats were removed. Normal beat-to-beat RR data were used to calculate HRV indices. Personal PM 2.5 nephelometry was used to estimate 24-h individual-level real-time PM 2.5 exposures. We use linear mixed-effects models to assess autocorrelation-and other major confounder-adjusted regression coefficients between 1-6 h moving averages of PM 2.5 and HRV indices. The increases in preceding 1-6 h moving averages of PM 2.5 was significantly associated with lower HF, LF, and SDNN, with the largest effect size at 4-6 h moving averages and smallest effects size at 1 h moving average. For example, a 10 mg/m 3 increase in 1 and 6-h moving averages was associated with 0.027 and 0.068 ms 2 decrease in log-HF, respectively, and with 0.024 and 0.071 ms 2 decrease in log-LF, respectively, and with 0.81 and 1.75 ms decrease in SDNN, respectively (all P-values o0.05). PM 2.5 exposures are associated with immediate impairment of CAM. With a time-course of within 6 h after elevated PM 2.5 exposure, with the largest effects around 4-6 h.
Introduction
Recently, both scientific and regulatory communities have focused their attention on the evidence of the adverse effects of air pollution on cardiovascular disease. Numerous studies have consistently shown that exposure to ambient air pollution, especially fine particulate matters with aerodynamic diameter o2.5 mm (PM 2.5 ), is associated with increased cardiopulmonary mortality and morbidity (Dockery et al., 1993; Peters et al., 2000 Peters et al., , 2001a Pope et al., 2002; Brook et al., 2004) . Previous studies have proposed several hypothesized mechanisms for PM-related adverse cardiac effects, including autonomic modulation impairment (Liao et al., 1999; Gold et al., 2000; Magari et al., 2001; Park et al., 2005; Luttmann-Gibson et al., 2006) , prolonged ventricular repolarization (Yue et al., 2007; Lux and Pope, 2009) , PM-induced oxidative stress (Srensen et al., 2003) , systematic inflammation (Ridker et al., 1997; Peters et al., 2001b) , and blood coagulation (Ghio et al., 2000; Schwartz, 2001) . The findings from the PM effects on cardiac autonomic modulation were the most consistent among these competing mechanisms. Together with the large body of evidence supporting that impaired cardiac autonomic modulation (CAM) is associated with increased risk of incident coronary heart disease, sudden cardiac death, and all cause mortality (Martin et al., 1987; Tsuji et al., 1994; Liao et al., 1997) , PM effects on CAM has emerged as one of the most promising mechanisms responsible for the link between PM and cardiac disease risk.
To date, however, few published studies have investigated the time course of the PM effect on CAM. Therefore, we carried out this study to investigate the CAM effects and time course of individual-level exposures to PM 2.5 in a community-dwelling sample of healthy individuals.
Methods

Population
The data collected for the Air Pollution and Cardiac Risk and its Time Course (APACR) Study are used for this report. The APACR study, funded by NIEHS (1 R01 ES014010), was designed to investigate the mechanisms and the time-course of the adverse effects of PM 2.5 on cardiac electrophysiology, hemostasis, thrombosis, and systemic inflammation. All study participants were recruited from community-dwelling individuals residing in central Pennsylvania, mostly from the Harrisburg Metropolitan area. The inclusion criteria for the APACR Study included those who were 445 years of age, non-smokers and not having severe cardiac problems (defined as diagnosed valvular heart disease, congenital heart disease, acute myocardial infarction or stroke within 6 months or congestive heart failure). The NIH-funded Penn State College of Medicine General Clinical Research Center (GCRC) Community Recruitment Specialists and GCRC-organized community outreach activities supported subject recruitment. The GCRC maintains a list of community-dwelling individuals for various healthrelated studies. The APACR study participants were numerated from the GCRC's potential participants list. All study participants were examined between November, 2007 and June, 2009 . We approached approximately 75% of the individuals who met our inclusion criteria and enrolled in the study. Our targeted sample size was 100 individuals, and we enrolled and examined 106 individuals for the APACR study.
Study participants were examined in the GCRC in the morning between 0800 and 1000 h on day-1. All participants fasted for at least 8 h before the clinical examination. After completing a health history questionnaire, a trained research nurse measured seated blood pressure three times, height and weight, and drew 50 ml of blood for biomarker assays according to the blood sample preparation protocols. A trained investigator connected the PM 2.5 and Holter ECG recorders. Participants were given an hourly activity log to record special events that occurred over the next 24 h, including outdoor activities, exposure to traffic on the street, traveling in an automobile, and any physical activities. The entire clinical examination session lasted about 1 h. Participants were then released to proceed with their usual daily routines. The next morning, the participants returned to the GCRC to remove the PM and Holter monitors, deliver the completed activity log, have another 50 ml of blood drawn, and the collection of a urine sample. Then, an exercise echocardiography was performed on each participant according to a standardized protocol to measure the participant's ventricular function and structure. The entire day-2 session lasted for about 1 h and 45 min. Penn State University College of Medicine Institutional Review Board approved the study protocol. Each participant was reimbursed $50, one breakfast certificate in the hospital cafeteria, and the mileage of the transportation required for participating in the APACR study.
Personal Exposure Monitoring
A personal DataRam (pDR, model 1200, Thermo Scientific, Boston, MA, USA) was used in combination with a PM 2.5 size-selective inlet driven by a 1.5 l/min pump to obtain the personal real time 24-h PM 2.5 exposure estimates. The pDR, size-selective inlet, and the pump were fixed into the inside of a modified and locked 6 Â 6 Â 9 inch solid lunch box with the inlet open toward the outside of the lunch box. The pDR is a lightweight, self-recording optical nephelometer that uses light scattering physics of the fine particles to detect the realtime concentrations of particles of various sizes. This monitor has been widely used in other human exposure panel studies investigating human exposure factors as well as integrated exposure/epidemiological studies involving lung function and cardiovascular and other observable health effects (Reed et al., 2000; Rea et al., 2001; Wallace et al., 2005; Williams et al., 2009) . The device has a response that is a function of the number and mean aerodynamic size of the particles entering its optical chamber. The resulting response is then directly proportional to a calibrated particle range of PM 2.5 -sized aerosol. This calibration was performed by the manufacturer just before the start of the field study. The PM 2.5 particle size selection was achieved by using an active pump with a cyclone inlet (KTL SCC1.062, BGI Inc., Waltham, MA, USA) at a flow rate of 1.5 l/min. The standard operation procedure (SOP) for the use of pDR, including the pump volume setting, zeroing, calibration, filter loading, application, data transfer, and data validation, as well as chemical analysis of filters for major PM 2.5 species, were developed by the APACR investigators (Penn State University, 2008a). The standardized procedures were rigorously followed before and right after each use of the pDR. For this report, the real-time PM 2.5 concentrations originally recorded at 1-min intervals over the 24-h sampling period were summarized as 30-min segment means. Therefore, each participant contributed 48 PM 2.5 concentration data points in this report.
Continuous Ambulatory Electrocardiogram (Holter ECG)
The collection of heart rate data in panel studies has been widely reported as a means to investigate the effects of environmental exposures (Liao et al., 1999; Park et al., 2005; Luttmann-Gibson et al., 2006) . In this study, a high fidelity (sampling frequency 1000 Hz) 12-lead HScribe Holter System (Mortara Instrument) was used for 24-h Holter beat-to-beat ECG data collection. The high fidelity ECG significantly increases the resolution and enhances the accuracy of various wave form measurements. The Holter ECG data are scanned to a designated computer for offline processing by an experienced investigator using specialized SuperECG software (also developed by Mortara Instrument). The SOPs for the APACR study have been developed by the study investigators (Penn State University, 2008b, c) and were rigorously followed in the data collection and interpretation processes. Briefly, the ''Holter ECG Data Collection and Analysis Procedures'' (Penn State University, 2008b) were followed rigorously to prepare, hook-up, calibrate, and start the Holter digital recorder. After 24 h of recording, a trained investigator followed the SOP to retrieve and archive the beat-to-beat ECG data for offline processing. The main objective of the offline processing was to verify the Holter-identified ECG waves, and to identify and label additional electronic artifacts and arrhythmic beats in the ECG recording. Finally, a single research investigator followed the ''SuperECG Manual,'' (Penn State University, 2008c) to perform beat-to-beat ECG analysis to calculate ECG parameters.
HRV Data
We performed time and frequency domain heart rate variability (HRV) analysis on the ECG recording after removing artifacts and ectopic beats with standardized visual inspection. We calculated HRV indices from each 30-min segment using the SuperECG package (Mortara Instrument) according to the current recommendations (Task Force, 1996) . The following HRV indices were used as indices of CAM: SD of all normal RR intervals (SDNN, ms), square root of the mean of the sum of the squares of differences between adjacent RR (RMSSD, ms), heart rate (beat per min), power in the low frequency range (0.04-0.15 Hz, LF), power in the high frequency range (0.15-0.40 Hz, HF), and the ratio of LF and HF (LF/HF).
Weather Variables
We obtained real-time temperature and relative humidity using the HOBO H8 logger (Onset Computer Corporation, Bourne, MA, USA), directly fixed on top of the lunch box housing the pDR. The real-time temperature and relative humidity were recorded at 1-min intervals initially. For each participant, we calculated 30-min segment-specific averages, corresponding to the PM 2.5 and Holter measures. Therefore, these weather covariables are treated as repeated measures, and each individual contributed 48 data points for each variable.
Other Participant Level Co-Variables
A standardized questionnaire administered on day-1 of the study was used to collect the following individual-level information: (a) demographic variables, including age, race, sex, highest education level; (b) medication uses, including anti-anginal medication, anti-hypertensive medication, and anti-diabetic medication; and (c) physician-diagnosed chronic disease history, including CVD (including revascularization procedures and myocardial infarction), hypertension, and diabetes. The averages of the 2nd and 3rd measures of seated systolic and diastolic blood pressures on day 1 were used to represent a participant's blood pressure levels. Day-1 fasting glucose was measured by Penn State GCRC central laboratory. CVD was defined by anti-anginal medication use or a history of CVD. Hypertension was defined by antihypertensive medication use, physician-diagnosed hypertension, systolic blood pressure Z140 mm Hg, or diastolic blood pressure Z90 mm Hg. Diabetes was defined by anti-diabetic medication use, physician diagnosed diabetes, or fasting glucose 4126 mg/dl. Body mass index (BMI) was defined as the ratio of weight to height squared (BMI, kg/m 2 ).
Statistical Analysis
We treated HRV, PM 2.5 , and the weather variables as repeated measurements in 30-min segments; thus, each individual contributed 48 data points for each of these variables. In some individuals, because of accidental detachments of the ECG electrodes, the total length of usable ECG data within certain segments was less than 20 min (2/3 of the total 30 min). These segments were excluded from our regression analysis. As a result, this report included 5050 pairs (out of a total of 5088 possible pairs from 106 individuals) of 30-min-based PM 2.5 and HRV data in the regression analysis. For each individual, we calculated the 24-h overall PM 2.5 , temperature, and relative humidity based on 48 data points. From these individual averages, we then calculated the 24-h overall exposures for our study population. One to six hour moving average PM 2.5 concentrations were also calculated for each 30-min segment HRV index. These moving averages were calculated in two ways: (1) using all available data points regardless of the amount of missing data (e.g., five 30-min segment means were used to calculate a 2-h moving average) or (2) the 75% rule approachFwe calculated these moving averages when at least 75% of the total data points were present within the respective moving average time frame (e.g., at least 90 min of PM 2.5 data (four 30-min segment means) were required for a 2-h moving average calculation). For each individual, we calculated the 24-h means of the 1-6 h moving averages, and then from these individual mean moving averages we calculated the 24-h overall exposures for our study population on each of the six moving averages we reported here. In the regression analysis associating PM 2.5 moving averages to 30-min-based repeated HRV variables, we confirm the finding from the first approach with that from the second approach to the moving average calculation. We used linear mixed-effect models to assess the autocorrelation corrected regression coefficients between 1-6 h moving average PM 2.5 concentrations and the 30-min HRV measures. All associations were adjusted for age, sex, race, temperature, relative humidity, diabetes, hypertension, and history of CVD. We used the SAS statistical package (version 9; SAS Institute, Cary, NC, USA) for all analyses. All results were expressed per 10 mg/m Table 1 presents the time independent demographic and clinical characteristics, and the time-dependent HRV indices.
Results
The mean age of the participants was 56 years, with 74% non-Hispanic white, 59% females, and 43% having chronic diseases (CVD, hypertension, or diabetes). The prevalence of CVD, hypertension, and diabetes was 8.5, 34.9, and 7.6%, respectively. Figures 1 and 2 show the time of the day-specific distribution (mean and SD) of the PM 2.5 levels and log-HF as an example of HRV indices calculated from the entire set of study participants. The overall average 24-h exposure to PM 2.5 and its SD, as well as the mean of 1-6 h based moving averages and their SD are presented in Table 2 . From these summary statistics, both environmental and HRV variables presented significant variation over the study period. The environmental variables also showed large inter-individual variations. However, as expected, since all the moving average concentrations were calculated from the same 48 data points for each individual, there was little variation among the six moving averages of PM 2.5 exposures in Table 2 . Multivariable-adjusted regression coefficients and SE for the associations between PM 2.5 and HRV indices are presented in Table 3 . As indicated in the table, there is a significant inverse relationship between PM 2.5 and log-HF, log-LF, and SDNN in 1-6 h. An increase in PM 2.5 concentration in the preceding 3-5 h was also significantly associated with elevated heart rate. LF/HF ratio and RMSSD were not statistically significant associated with PM 2.5 . The pattern of association between elevated PM 2.5 and HRV variables remained unchanged after additional adjustment for chronic diseases. The association between PM 2.5 and HRV indices did not change substantially when we applied the 75% available data rule in the calculation of the moving averages (Model 3 in Table 3 ).
Discussion
Recently, various studies have suggested several important potential underlying mechanisms that link PM 2.5 air pollution and cardiac disease (Ridker et al., 1997; 2007). One of the most promising potential mechanisms is the adverse effect of fine particle air pollution on cardiac autonomic modulation. Specifically, increased PM 2.5 concentration may result in imbalanced cardiac autonomic modulation, that is, a reduced parasympathetic and increased sympathetic modulation. This PM 2.5 -HRV association has been shown to be acute in terms of occurring within days (Liao et al., 2004; de Hartog et al., 2009) . However, to our knowledge, few studies have systematically examined the exact time-course of the PM effect on HRV.
The data from this community-dwelling sample of healthy non-smokers confirmed a significant adverse association between elevated individual-level exposures to PM 2.5 and CAM. Most importantly, these data indicated that the time course of the PM 2.5 effect on CAM occurred acutely, all within 6 h of exposures to elevated PM 2.5 with the strongest effects occurring between 4 and 6 h. Other studies have indicated several potential mechanisms that link PM pollution and cardiovascular disease risk. These mechanisms ranged from shorter term to longer term effects of PM. The former included shorter term PM effects on CAM ( (Liao et al., 1999; Park et al., 2005) , on lowered threshold of arrhythmia (Huikuri et al., 2001; Liao et al., 2009 ), on potential myocardium ischemia (Zhang et al., 2009 ), on ventricular repolarization (Yue et al., 2007; Lux and Pope, 2009) , and on blood coagulation (Liao et al., 2005) The latter included longer-term PM effects on atherosclerosis and plaque rupture (Suwa et al., 2002; Sun et al., 2005) , on prothrombin time and on thrombosis risk (Baccarelli et al., 2008) . Our time course-results are suggestive of an acute adverse effect of PM 2.5 on CAM impairment. Such an acute effect on CAM suggests an acute triggering effect of PM 2.5 in terms of its mechanistic impact on the onset of cardiac events, such as arrhythmia and sudden cardiac death.
It is worthwhile noting that several previous studies reported chronic cardiopulmonary disease as a significant effect modifier in the relationship between PM air pollution and decreased HRV, indicating higher susceptibility to an air pollution effect on HRV among persons with cardiopulmonary conditions (Holguı´n et al., 2003; Liao et al., 2004; Park et al., 2005) . In this study, however, we did not find a significant interaction between PM 2.5 concentration and history of CVD or diabetes. This may be due to the small number of participants who had a positive history of CVD (N ¼ 9) or diabetes (N ¼ 8). Given that the total length of data collection on both HRVand PM was 24 h in parallel, we chose to analyze the exposure and outcome association up to a 6-h moving average only, since moving averages of longer duration would lead to a significant proportion of the calculated moving averages being based on the same set of data points. Thus, a significant proportion of the longer-term moving averages would be identical to the shorter-term moving averages.
When comparing with previous studies, one of the strengths of this study is using individual-level PM 2.5 concentration measured on a real-time basis over 24 h. For example, in the EPA Baltimore study (Liao et al., 1999) , PM concentration was measured from a monitor located in the center of a retirement facility. In the Atherosclerosis Risk in Communities Study (Liao et al., 2004) , and in the Women's Health Initiative Study , the PM concentrations were mathematically estimated either using a simple area average of the ambient concentrations (Liao et al., 2004) , or the spatial correlation based ambient estimations at the participant's primary homes . These studies all relied on the ambient exposure data at the community or the residence levels, which may not be representative of the true exposures that the study participants experienced. In contrast, this study used a personal PM 2.5 , which enabled us to capture individual-level exposures during the entire 24-h period. The individual level exposure and health outcome data collected in this study allow us the opportunity to better model the PM 2.5 and CAM association much more efficiently and it also enabled us to ''control'' for many individual-level unmeasured factors that may influence the CAM measures. We also treated both the exposure and outcome data as 30-min-based repeated measures, and thus benefited from increased statistical power in associating the PM exposures to HRV variables.
Although the results generated from this study are compelling, there are still several limitations. First, we excluded smokers and people who had severe cardiac events in the past 6 months. Therefore, one may not be able to generalize the association seen in these data to individuals with more severe cardiovascular disease. It is possible that the PM 2.5 effect on HRV might be greater in individuals with underlying structural heart disease, ischemic heart disease, or heart failure. Secondly, the effect sizes we identified in this study are relatively small, but this is consistent with previous studies of the PM effect on HRV (Liao et al., 1999; Luttmann-Gibson et al., 2006) . Thirdly, majority of the participants reported that they stayed indoors most of the time during the 24-h study period, except when they had to travel by automobile. This behavior pattern is reflected in the relatively low levels of exposure to PM 2.5 . In general, our participants had limited indoor exposures, such as secondhand smoking. Thus, we were unable to assess whether exposures at much higher levels would show similar associations. However, we purposely used the personal monitors and real-time Holter system to collect the true individual-level exposure and routine ECG data, respectively. We argue that the associations we observed in these individuals are more reflective of their routine exposure and outcome associations. Fourth, the ECG data from Holter were not collected under a controlled, supine position setting. Thus, the short-term variation of other factors that may impact the HRVcannot be fully accounted for. However, it is not feasible to keep a healthy participant in a supine indoor position for 24 h. Even if this were achieved, the results from such a study design would likely have limited variation in PM 2.5 exposure levels, and would have limited utility for generalization to a real world situation. In contrast, our study captures the range of activities occurring in real life, including time spent outdoors, time spent in commuting in automobile, and various other activities associated with a disease-free community-dwelling individual. Lastly, the pDR-estimated PM 2.5 concentrations over 24 h were used in this study as an estimation of personal exposures. This nephelometric device responds to the optical properties of the particles it encounters rather than the true particle gravimetric properties. It should be recognized that the optical properties calibrated using Arizona road dust might not be highly representative of the actual PM 2.5 aerosol the study participants encountered. Previous studies have reported that the Arizona road dust calibrated pDR, identical to the one used in this study provides mass concentration estimates in good agreement with that from gravimetric mass-based measures (correlation coefficients 40.8), but the pDR often yield estimates 10-50% higher than that from gravimetric mass-based measures (Reed et al., 2000; Rea et al., 2001; Williams et al., 2009 ). Based on these validation studies, the personal exposures used in this study might be slight, but systematically overestimate the true environmental conditions that existed. However, such a systematic overestimation of the true exposures to PM 2.5 should not have biased the pattern of the observed associations. It can be argued that the reported effect sizes per 10 mg/m 3 increase in the pDR estimated PM 2.5 actually represent effect sizes of only 6.67-9.00 mg/m 3 increase in the true PM 2.5 exposure, if pDR systematically overestimates the true exposure by 10-50%. In other words, the reported effect sizes in this study were systematically underestimated.
In conclusion, these data confirmed a significant adverse relationship between individual-level PM 2.5 exposures and cardiac autonomic modulation as measured by HRV indices toward a reduced parasympathetic modulation and an increased sympathetic outflow. Most importantly, our data suggest that the effect of elevated PM 2.5 exposure on impaired CAM occurred within 6 h after elevated PM 2.5 exposures, with the strongest effects occurring between 3 to 6 h. Such an acute effect of PM 2.5 on CAM may contribute to acute increase in the risk of cardiac disease, or trigger the onset of acute cardiac events, such as arrhythmia and sudden cardiac death.
